A new investigation of FDA-approved Alzheimer’s drug donanemab highlights concerns about excess deaths, missing safety data, and financial conflicts of interest among FDA advisory panel members who recommended approval.
A single-dose gene therapy has demonstrated significant reduction in bleeding episodes for adults with haemophilia B, potentially offering a long-term solution to this genetic disorder.
A new study finds that most cardiovascular devices subject to the most serious recalls by the US FDA lacked rigorous clinical testing before approval, raising concerns about patient safety.
A comprehensive analysis of FDA-approved artificial intelligence medical devices reveals significant gaps in clinical validation, raising concerns about their effectiveness and safety in real-world healthcare settings.
Oticon Medical has announced that its Sentio System, the company’s first active transcutaneous bone conduction hearing system, has received clearance from the U.S. Food and Drug Administration (FDA). This innovative system aims to provide the established benefits of the company’s Ponto System whilst offering a transcutaneous option.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Sammy Chouffani El Fassi